CARDIOLOGY

• Worldwide CVD data and Nuclear Cardiology utilization.

Jo?o Vitola, MD, PhD (Brazil), IAEA Expert

• New developments in radiopharmaceuticals and tracers.

Francisco Zayas, PhD (Cuba)

• Multimodality imaging approach to evaluate CAD: US, CT, MRI, SPECT/PET.

Erick Alexanderson, MD (Mexico), IAEA Expert

• State of the art of cardiac CT.

Luis R. Llerena, MD, PhD (Cuba)

• State of the art of Nuclear Cardiology: new cameras and protocols.???????????????????????

Jo?o Vitola, MD, PhD (Brazil), IAEA Expert

• Intima-media thickness. Usefulness in clinical practice.

Juan Valiente, MD (Cuba)

• CT calcium scoring: complementary to perfusion imaging. Prognostic value.

Erick Alexanderson, MD (Mexico), IAEA Expert

• Clinical Guidelines. How precise are they?

Lydia Rodríguez, BSc (Cuba)

• What do clinicians expect from imaging tests? Experience of a clinical cardiologist.

Kenia Padrón, MD (Cuba)

• Diagnostic algorithms for CAD assessment. When and how to use imaging techniques in a cost-effective manner. Data from clinical trials.

Fernando Mut, MD (Uruguay), IAEA Expert

• Emergency department: When and how to implement MPI.

Lázaro O. Cabrera, MD (Cuba)

• CAD in asymptomatic diabetic patients. Role of Nuclear Cardiology.

Amalia Peix, MD, PhD (Cuba)

• CAD diagnosis in women: How to understand the imaging approach.

Fernando Mut, MD (Uruguay), IAEA Expert

• Viability assessment: scar or jeopardized but viable myocardium as the imaging target?

Juan Batista, MD (Cuba)

• Autonomic Nervous System - MIBG, the impact on heart failure and sudden cardiac death risk stratification.

Jo?o Vitola, MD, PhD (Brazil), IAEA Expert

• Clinical Importance of the evaluation of myocardial blood flow with PET.?? ????

Erick Alexanderson, MD (Mexico), IAEA Expert

• Perfusion and non-perfusion risk parameters derived from Gated SPECT.

Fernando Mut, MD (Uruguay), IAEA Expert